Interestingly, Cluster-6 shows expression for stemness markers CD117 and CD44, the tumor markers CD125, HE4 and EpCAM, and is negative for the immune and stromal markers, presenting as a potential cancer stem cell population. This evidence concerns the gene WFDC2 and neoplasm.